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insertional sites of ligaments and muscles, the outer third of the
menisci and, possibly, the synovium but their role is uncertain.
Reported structural correlates of OA pain include the association
between knee pain and minimal cartilage lesions, alterations in
patellar cartilage volume, osteophytes, bone marrow edema, joint
effusion and synovial thickening, and periarticular lesions includ-
ing bursitis and iliotibial band syndrome. However, a controversy
about each of the reported structural correlates remains:
Cartilage. Prior studies demonstrate a poor association between
knee pain and cartilaginous defects. Only a few studies demon-
strate an association between the two. One of them states that
most symptoms are found in patients with grade IIa cartilage
lesions. They hypotisized that clinical symptoms are most sub-
stantial at the onset of OA, when cartilage defects occur.
Osteophytes. Some studies demonstrate an association between
osteophytes and knee pain. They associate OA pain with an
osteophyte located in the patellofemoral compartment, at the
inferior pale of the patella, at the medial tibial plateau, or when
more than four osteophytes anywhere in the knee were present.
An association between central osteophytes and knee stiffness,
but not knee pain, was suggested in yet two other studies.
Bone marrow edema. The role of BME in OA is controversial,
as contradictory results have been reported. BME have been
associated with clinical symptoms in patients with OA in several
studies. BME is associated with progression of OA as assessed
by joint space narrowing on conventional radiographs. On the
other hand, other studies report no association between BME
and clinical symptoms, or with progression of disease.
Joint effusion. In the literature a controversy exists about the
association between joint effusion and knee pain. Some studies
ﬁnds that moderate and severe effusions (grade 2 and 3) were
signiﬁcantly more common among those with knee pain com-
pared to those without in patients with knee OA, others don’t.
An explanation for the association between pain and joint effu-
sion is given in different studies by the suggestion that capsular
distention is the cause of knee pain.
Baker’s cysts. No association was found between the presence
or grade of a Baker’s cysts and clinical features. Popliteal cysts
are as common in patients with knee pain as in those without.
Meniscal tears. No association was found between meniscal
tears in patients with OA and clinical features.
The fact that most structural correlates of OA pain are contro-
versial is important with regards to future clinical trials, as it
urges conservatism with regards to the idea of a single struc-
tural feature being an outcome measure for progression of the
disease. A further quest to identify ideal parameters to quantify
the progression of the disease, and ﬁnd a structural correlate of
OA pain, is needed.
TARGETING MMPS AND ADAMTSS IN OSTEOARTHRITIS
H. Nagase
Imperial College London, London, United Kingdom
Purpose: Degradation of the cartilage matrix seriously impairs
the function of joints. The primary cause of this process is ele-
vated levels of proteolytic enzymes; primarily collagenases which
are members of the matrix metalloproteinase (MMP) family, and
aggrecanases that belong to the related family of metallopro-
teinases with disintegrin and thrombospondin motifs (ADAMTSs).
Synthetic inhibitors of these metalloproteinases are therefore po-
tential therapeutic agents, but those with a zinc-chelating moiety
directed against the active site showed serious side effects in
clinical trials, possibly due to lack of selectivity. With the aim of
developing new types of inhibitors, we have been investigating
the mechanism of action of collagenases and aggrecanases and
engineered more selective variants of the tissue inhibitors of
metalloproteinases (TIMPs).
Methods: Mutagenesis-based structural and functional stud-
ies of MMP-1 (collagenase 1), ADAMTS-4 (aggrecanase 1),
ADAMTS-5 (aggrecanase 2) and TIMP-3; Molecular modelling;
Pig cartilage explant culture to analyze cartilage degradation
in vitro and enzyme inhibition kinetics to investigate the mode
of action of calcium pentosan polysulfate (CaPPS) as a car-
tilage protectant; OA model induced by meniscotibial ligament
transection using transgenic mice over-expressing TIMP-3 or its
aggrecanase-selective mutant.
Results: Typical collagenases consist of a catalytic domain and
a hemopexin (Hpx) domain that are connected by a linker region.
Using MMP-1 we have shown that collagenase locally unwinds
triple helical collagen before it hydrolyzes the peptide bonds and
this reaction requires cooperativity of the catalytic and Hpx do-
mains. Mutagenesis studies suggested that the putative collagen
binding-site is created by both the catalytic and the Hpx domains.
This potential collagen binding groove is partially blocked by the
pro-domain in the zymogen of MMP-1 (proMMP-1) and may be
a suitable site to target with an exosite inhibitor.
Domain deletion mutagenesis studies of ADAMTS-4 and
ADAMTS-5 indicated that the non-catalytic domains of the ag-
grecanases play pivotal roles in substrate recognition and aggre-
canolysis. CaPPS inhibits the aggrecanase activity of ADAMTS-4
and ADAMTS-5 as an exosite inhibitor by interacting with their
non-catalytic domains. When added to cartilage, CaPPS binds
to TIMP-3 secreted by chondrocytes and blocks LDL receptor-
related protein (LRP)-mediated internalization of TIMP-3. This
accumulates TIMP-3 in the cartilage and the CaPPS-bound
TIMP-3 is a much more effective inhibitor of ADAMTS-4 and
ADAMTS-5, but not of MMPs.
We engineered TIMP-3 mutants [(-1Ala)N-TIMP-3, (-2Ala-Ala)N-
TIMP-3 and N-TIMP-3(T2G)] that inhibit ADAMTS-4 and -5, but
not MMPs. Over-expression of either the wild-type TIMP-3 or
(-1Ala)TIMP-3 in transgenic mouse cartilage prevented cartilage
degradation in a surgically-induced OA model.
Conclusions: Highly selective inhibitors are required for suc-
cessful metalloproteinase inhibitor therapy of OA.
Structural and functional studies of collagenases and two aggre-
canases indicate that inhibitors that interact with the non-catalytic
domains of these multidomain metalloproteinases will achieve
selectivity.
CaPPS is a unique exosite inhibitor of aggrecanases. In cartilage,
it exhibits three modes of action to block aggrecan breakdown.
Protection of cartilage from degradation in an OA mouse model
by over-expressing an aggrecanase-selective TIMP-3 variant
suggests that aggrecanase may be a good target for therapeutic
intervention in OA.
This work was supported by grants from the Wellcome Trust,
Arthritis Research Campaign and National Institutes of Health
(USA).
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The mature articular chondrocyte embedded in the cartilage ma-
trix is a resting cell with no detectable mitotic activity and very
low synthetic activity. As the single cellular constituent of adult
articular cartilage, chondrocytes are responsible for maintaining
the cartilage matrix in a low turnover state of equilibrium. Since
chondrocyte metabolism in situ occurs in low oxygen tension and
is remote from a vascular supply, it is not surprising that changes
in expression of cartilage matrix constituents occur in isolated
chondrocytes in monolayer culture, where they increase syn-
thetic activity by several orders of magnitude. Primary cultures
have provided useful models for studying cellular responses to
alterations in the environment such as those occurring in different
forms of arthritis. Nevertheless, the source of the cartilage cannot
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be controlled with respect to donor-to-donor variability in disease
severity and age, sufﬁcient numbers of cells are not readily ob-
tained from random operative procedures, and the phenotypic
stability and proliferative capacity are lost upon serial subculture.
Since the stability of the phenotype of isolated chondrocytes is
critically dependent on cell shape and cell density, high-density
micromass cultures are useful if sufﬁcient numbers of chondro-
cytes are isolated. It is also possible to expand the cultures
through a limited number of passages and re-differentiate the
cells in ﬂuid or gel suspension culture systems, where the chon-
drocytes regain morphology and the cessation of proliferation
is associated with re-expression of cartilage phenotype. Culture
systems that support chondrocyte phenotype include suspension
culture in spinner ﬂasks, in dishes coated with a non-adherent
substrates, in pellets, and in 3-dimensional matrices such as
collagen gels, agarose, alginate, or collagen sponges. Serum-
free deﬁned media of varying compositions, but usually including
insulin, have also been used, frequently in combination with the
other culture systems mentioned above. In explant cultures of
articular cartilage, the chondrocytes remain encased within their
own extracellular matrix and cellular function can be assessed
by immunohistochemistry or in situ hybridization. Immortalized
chondrocytes of human origin have been developed by sev-
eral laboratories to serve as reproducible models for studying
chondrocyte function. However, expansion of primary or immor-
talized chondrocytes in monolayer culture results in decreased
expression of phenotypic markers, particularly if high cell density
is not maintained. Suspension culture systems may be used
to re-induce or maintain the expression of chondrocyte-speciﬁc
markers. Retroviral transduction of SV40-TAg, HPV-16 E6/E7,
or telomerase has been used somewhat successfully to im-
mortalize primary human chondrocytes. However, the source
and developmental state of the isolated chondrocytes, e.g. adult
articular or juvenile costal, have inﬂuence on the retained charac-
teristics such as proliferative capacity and differentiated pheno-
type. We have used immortalized human chondrocyte cell lines
most successfully in studies requiring large numbers of cells,
including assays of COL2A1 and MMP-13 promoter activities
in luciferase reporters in response to cytokine treatments and
overexpressed transcription factors, EMSA analysis using nu-
clear extracts, chromatin immunoprecipitations, and microarray
analyses. Immortalized chondrocytes are not considered as sub-
stitutes for primary chondrocytes, in which deﬁnitive experiments
should be repeated, but they serve as useful tools for evaluating
and further validating mechanisms relevant to cartilage biology.
BIOMECHANICS OF OBESITY
S.P. Messier
Wake Forest University, Winston-Salem, NC
Obesity has a detrimental effect on biomechanical measures
of function, including strength, balance, foot pressure, and gait.
This workshop will review the related obesity literature, including
the work of Hills, and DeVita as well as our own that will
illustrate the tremendous burden obesity places on function. In
addition, our work with obesity centers around its status as a
major risk factor for knee osteoarthritis. Hence, this workshop
will include the results of our work with obese adults with knee
osteoarthritis. Obesity is well known as a major risk factor for
type II diabetes and heart disease, however, less is known about
its inﬂuence on strength and movement. This workshop will
demonstrate how obesity negatively inﬂuences the way we move,
resulting in orthopaedic problems and osteoarthritis. Finally, the
positive effects of weight loss, either through diet and exercise or
surgically induced will be discussed.
DOES SUBCHONDRAL BONE TISSUE REMODELING OR
CELL FUNCTION PLAY A ROLE IN ARTICULAR
CARTILAGE LOSS IN OSTEOARTHRITIS?
D. Lajeunesse
CRCHUM, Hôpital Notre-Dame, Montréal, PQ, Canada
Purpose: Osteoarthritis (OA) is the most common form of arthri-
tis and accounts for billions in health and economical expenses
in North America. OA is characterized by cartilage damage and
loss, synovial membrane inﬂammation, bone sclerosis and the
formation of osteophytes. Clinical and in vitro studies suggest
that subchondral bone sclerosis and altered bone remodeling,
due to abnormal osteoblasts (Ob), is involved in the progression
and/or onset of OA. Several recent investigations have keyed in
on the understanding of bone changes that may account for joint
deterioration and development of OA. The hypothesis of a possi-
ble role for subchondral bone in the initiation and progression of
cartilage degeneration speculates that the increase in bone mass
and thickness could have modiﬁed the biomechanical properties
of the tissue and could have favored the appearance/progression
of articular cartilage structural changes.
Methods: Many studies have demonstrated that the subchondral
bone is the site of several dynamic morphological changes that
vary over time during the evolution of the disease and seem to
be part of the disease process. Here we reviewed the evidence
that OA Ob are responsible: i) to maintain this abnormal mineral-
ization, ii) to release factors that can modify both osteoblasts and
chondrocytes functions, and iii) to degrade articular cartilage.
Results: Individuals with OA exhibit striking increases in bone
mass for affected sites, such as the knee and hip, as well as
non-synovial sites, such as the lumbar spine. OA individuals
also show increases in body mass index (BMI). This increase
in bone mass is due to an abnormal metabolism of Ob as
observed in vivo and in vitro, and most particularly in the sub-
chondral bone tissue. These alterations of Ob from the sub-
chondral bone tissue do not appear to be the consequence
of a change in serum levels of humoral factors or hormones,
but a response to altered local signals. OA Ob could show ab-
normal features due to paracrine/autocrine signals and indeed,
OA Ob release abnormal levels of a number of growth factors,
cytokines/chemokines and eicosanoids such as prostaglandins
(PGs) that may all be involved both in abnormal Ob and chon-
drocytes cellular function. Growth factors such as Insulin-like
growth factor-1 (IGF-1), Transforming growth factor-Î21 (TGF-
Î21) and Hepatocyte growth factor (HGF) are all released more
abundantly by OA Ob and have direct effects on Ob functions,
osteophyte formation and cartilage catabolism. OA Ob release
more Interleukin-6, CXCL12, CXCL13 and leptin that can also
directly modulate type 1 collagen synthesis, promote articular
cartilage degradation, and contribute to the inﬂammatory state
observed in OA. Last, OA Ob release variable levels of PGE2, a
situation that is related to both abnormal in vitro mineralization
and altered cartilage catabolism. A number of key studies have
indicated that conditioned-media from OA Ob alter chondrocyte
cell functions and can degrade articular cartilage. However, we
still do not know what this putative factor(s) is.
Conclusions: In conclusion, theses studies suggest that the
mechanism(s) that lead to abnormal mineralization of OA bone
tissue observed in vivo and those that lead to articular carti-
lage degradation may be linked with the release of a putative
soluble factor(s) by OA Ob. Production of an abnormal collagen
matrix and a soluble factor(s) by OA Ob leads to an abnormal
osteoid matrix not mineralizing normally. This putative factor(s)
contributes to cartilage degradation but also to abnormal Ob cell
function.
